secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CIK:        0001595097
Form:       8-K
Filed at:   2025-11-03T23:59:59+00:00
Accession:  0001193125-25-261722
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Corbus Pharmaceuticals prices $75M public offering of common stock and warrants
-------------------------------------------------------------------------------

- Offering of 4,744,231 shares at $13.00/share and 1,025,000 pre-funded warrants at $12.9999 each for ~$75M gross proceeds.
- Net proceeds to Corbus expected ~$70.5M; underwriters have 30-day option for additional 865,384 shares.
- Proceeds to fund clinical pipeline development and general corporate purposes.
- Pre-funded warrants exercisable immediately at $0.0001/share, capped at 9.99% beneficial ownership.
- Jefferies leads underwriting; RBC, LifeSci Capital, Mizuho as lead managers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595097/000119312525261722/0001193125-25-261722-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595097/000119312525261722/crbp-20251030.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-261722

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer